Pacific Biosciences is the Overall Winner of the OnDC 100 Top Private Company Awards

AlwaysOn today announced the winners of its OnDC 100 Top Private Company Awards and named Pacific Biosciences the Overall Winner. Inclusion in the OnDC 100 signifies technology developments in healthcare, education, broadband infrastructure, green technology, enterprise and cybersecurity that contribute to the renewed and continued prosperity of our country.

To compile the first annual OnDC 100 List, AlwaysOn surveyed hundreds of venture investors, investment bankers and industry experts, receiving more than 400 nominations. The AlwaysOn editorial team and a panel of industry experts from KPMG, Morgan Stanley, Manatt, Silicon Valley Bank, Goodwin Procter, The Artimis Project, Revolution Partners and Bridge Bank evaluated the nominations based on five criteria: innovation, market potential, commercialization, stakeholder value, and media buzz.

“It’s no secret that technology and innovation are vital to bringing our country out of economic recession and transforming important sectors like energy and healthcare,” said Tony Perkins, founder and CEO of AlwaysOn. “We congratulate the OnDC 100 for their success in introducing new tools, services, and systems to address the nation’s top priorities.”

Overall Winner Pacific Biosciences has developed a platform for single-molecule real-time detection of biological events, a technology that promises radical advances in medicine and green technology.

The AlwaysOn OnDC 100 Top Private Companies will be honored at AlwaysOn’s OnDC event on October 19th-21st at the Four Seasons Hotel in Washington DC. This two-and-a-half-day executive event features CEO presentations and high-level debates on sectors most impacted by the federal government including greentech, on-demand computing and IT security, education, and the life sciences.

A full list of all the OnDC 100 Top Private Companies and category winners can be found on the AlwaysOn website at: http://alwayson.goingon.com/permalink/post/33638

Source:

 AlwaysOn

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare